Zoledronic acid works by inhibiting osteoclast-mediated bone resorption. Osteoclasts are cells that break down bone tissue, a process that is often accelerated in the presence of cancerous cells. By inhibiting these cells, zoledronic acid helps to strengthen the bone and reduce the likelihood of fractures, pain, and other complications.
